GlassScriptPhysician profile
Felipe Findley
NPI 1992823579
$51,032.25
in general payments reported to CMS, 2019-2025
15 companies · $31K in 2025
The $31K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,992 · 2022: $4,724 · 2023: $7,594 · 2024: $5,127 · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Food and Beverage: $7,226 · Travel and Lodging: $4,738 · Consulting Fee: $3,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,432.50 |
| Food and Beverage | $7,225.94 |
| Travel and Lodging | $4,737.81 |
| Consulting Fee | $3,920.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $42,591.47 | 2021-2025 | Biktarvy, Yeztugo, Descovy |
| Viiv Healthcare Company | $6,830.97 | 2021-2025 | Apretude, Cabenuva, Dovato |
| Janssen Biotech, INC. | $291.88 | 2021-2023 | Symtuza |
| Neurocrine Biosciences, INC. | $251.52 | 2025 | |
| Merck Sharp & Dohme LLC | $245.48 | 2021-2025 | Pifeltro, Delstrigo, Capvaxive |
| Janssen Products, LP | $176.99 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $126.29 | 2021-2022 | |
| Emd Serono, INC. | $121.83 | 2024 | Serostim |
| Abbvie INC. | $107.56 | 2021-2025 | |
| Hologic Sales and Service, LLC | $100.30 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Napo Pharmaceuticals INC | $75.32 | 2022-2025 | Mytesi |
| Novo Nordisk INC | $40.37 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $28.48 | 2022 | |
| Glaxosmithkline, LLC. | $22.73 | 2025 | Shingrix |
| Exact Sciences Corporation | $21.06 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felipe Findley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.